Close Menu

NEW YORK (GenomeWeb) – Fulgent Genetics reported after the close of the market on Thursday that its fourth quarter revenues rose 33 percent year over year.

For the three months ended Dec. 31, 2018 the company reported revenues of $5.7 million, up from $4.3 million in Q4 2017. The firm said that it delivered 6,408 billable tests during Q4, an increase of 52 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.